Influencia de los antiinflamatorios no esteroideos en la hemorragia digestiva por úlceras o erosiones gastroduodenales en pacientes con cirrosis hepática
作者： M. Castro-Fernández , D. Sánchez-Muñoz , M.V. Galán-Jurado , J.L. Larraona , E. Suárez
DOI: 10.1157/13083251
关键词:
摘要: Resumen Introduccion La enfermedad peptica gastroduodenal, con o sin complicaciones, es mas frecuente en los pacientes cirrosis hepatica que la poblacion general y su patogenia influirian factores dependientes de hipertension portal. prevalencia infeccion por Helicobacter pylori similar a existente general. Se objetiva conocer influencia antiinflamatorios no esteroideos (AINE) etiologia patologia gastroduodenal hemorragia digestive hepatica. Pacientes metodos incluyo 35 digestiva ulceras erosions gastroduodenales (grupo A), 125 cirroticos, erosiones B) 70 ingresan C). En todos pacientes, mediante encuesta dirigida, se investiga el consumo AINE, incluido acido acetilsalicilico (AAS), semana previa al ingreso hospitalario. Resultados Referian AINE 15 (42,8%) del grupo A, 102 (58,2%) B 6 (8,5%) C. obtuvieron diferencias significativas comparar resultados A Conclusiones El bajo (8,5%), muy inferior observado (42,8%). puede considerar como sucede general, desempenarian un importantepapel e
elsevier.es
unirioja.es参考文章(20)
Jean Auroux, Gastroduodenal ulcer and erosions are related to portal hypertensive gastropathy and recent alcohol intake in cirrhotic patients Digestive Diseases and Sciences. ,vol. 48, pp. 1118- 1123 ,(2003) , 10.1023/A:1023772930681
Mario Miglioli, Roberto Corinaldesi, Luigi Bolondi, Sebastiano Siringo, Dino Vaira, Marcello Menegatti, Fabio Piscaglia, Soccorsa Sofia, Mariana Gaetani, High Prevalence of Helicobacter pylori in Liver Cirrhosis (Relationship with Clinical and Endoscopic Features and the Risk of Peptic Ulcer) Digestive Diseases and Sciences. ,vol. 42, pp. 2024- 2030 ,(1997) , 10.1023/A:1018849930107
Maria Dore, Daniela Mura, Stefania Deledda, Emmanouil Maragkoudakis, Antonella Pironti, Giuseppe Realdi, Active peptic ulcer disease in patients with hepatitis C virus-related cirrhosis: the role of Helicobacter pylori infection and portal hypertensive gastropathy. Canadian Journal of Gastroenterology & Hepatology. ,vol. 18, pp. 521- 524 ,(2004) , 10.1155/2004/150674
Chung-Jyi Tsai, Helicobacter pylori Infection and Peptic Ulcer Disease in Cirrhosis Digestive Diseases and Sciences. ,vol. 43, pp. 1219- 1225 ,(1998) , 10.1023/A:1018899506271
Jyh-Jou Chen, Chi-Sin Changchien, Dar-In Tai, Shue-Shian Chiou, Chuan-Mo Lee, Chung-Huang Kuo, Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. A serological study. Digestive Diseases and Sciences. ,vol. 39, pp. 1565- 1568 ,(1994) , 10.1007/BF02088065
Cheng-Shyong Wu, Chun-Yen Lin, Yun-Fan Liaw, Helicobacter pylori in cirrhotic patients with peptic ulcer disease: a prospective, case controlled study. Gastrointestinal Endoscopy. ,vol. 42, pp. 424- 427 ,(1995) , 10.1016/S0016-5107(95)70044-7
M. Michael Wolfe, David R. Lichtenstein, Gurkirpal Singh, Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. The New England Journal of Medicine. ,vol. 340, pp. 1888- 1899 ,(1999) , 10.1056/NEJM199906173402407
V De Lédinghen, D Heresbach, O Fourdan, P Bernard, M P Liebaert-Bories, J B Nousbaum, A Gourlaouen, M C Becker, D Ribard, P Ingrand, C Silvain, M Beauchant, Anti-inflammatory drugs and variceal bleeding: a case-control study Gut. ,vol. 44, pp. 270- 273 ,(1999) , 10.1136/GUT.44.2.270
Seigo Kitano, Baatar Dolgor, DOES PORTAL HYPERTENSION CONTRIBUTE TO THE PATHOGENESIS OF GASTRIC ULCER ASSOCIATED WITH LIVER CIRRHOSIS Journal of Gastroenterology. ,vol. 35, pp. 79- 86 ,(2000) , 10.1007/S005350050018
X. Calvet, M. Navarro, M. Gil, A. Lafont, I. Sanfeliu, E. Brullet, R. Campo, B. Dalmau, E. Rivero, P. Mas, Epidemiology of peptic ulcer disease in cirrhotic patients: role of helicobacter pylori infection The American Journal of Gastroenterology. ,vol. 93, pp. 2501- 2507 ,(1998) , 10.1111/J.1572-0241.1998.00711.X